tetrahydrocortisol has been researched along with Glaucoma, Suspect in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "3 alpha, 5 beta-tetrahydrocortisol, previously considered an inactive metabolite of cortisol, was found to lower significantly the intraocular pressure (IOP) of rabbits made ocular hypertensive with dexamethasone alone or with threshold levels of dexamethasone plus 5 beta-dihydrocortisol." | 3.67 | Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol. ( Gordon, GG; l'Hommedieu, D; Southren, AL; Weinstein, BI, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Southren, AL | 1 |
| l'Hommedieu, D | 1 |
| Gordon, GG | 1 |
| Weinstein, BI | 1 |
1 other study available for tetrahydrocortisol and Glaucoma, Suspect
| Article | Year |
|---|---|
Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol.
Topics: Animals; Dexamethasone; Glaucoma, Open-Angle; Humans; Hydrocortisone; Intraocular Pressure; Ocular H | 1987 |